Diabetes
-
Report: Employees Are More Focused on Immediate Health Goals Than Longer Term Goals
About 47% of American adults have hypertension and 14% have diabetes. Yet, 12% of people have set a goal to manage their blood pressure and 6% have a goal to manage their diabetes, a new HealthJoy survey found. Comparatively, about half of Americans have a musculoskeletal condition, and 35% of respondents are interested in managing back or joint pain.
-
TheracosBio Drug Approval Puts It in Competition With Blockbuster Diabetes Meds
The FDA approved TheracosBio’s Brenzavvy as a treatment for type 2 diabetes. But before it won a regulatory nod for controlling blood glucose in adults, it was approved at a different dose (with flavor) as a veterinary product.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Report: MA Performs Better Than Fee-for-service Medicare on Diabetes Care
Medicare Advantage patients with diabetes have higher prescription fill rates, fewer emergency department visits and lower total medical spending than traditional fee-for-service Medicare patients, a new report shows. They also received their diagnosis earlier.
-
Claiming Insulin Price Conspiracy, CA Sues Lilly, Novo Nordisk, Sanofi & PBMs
California’s Office of the Attorney General contends that drugmakers and pharmacy benefit managers work together to “aggressively raise the list price of insulin in lockstep with each other to artificial levels.” Insulin manufacturers deny the allegations, pointing to availability of lower-cost versions of their products.
-
Santa Clara Family Health Plan Taps Yes Health for Diabetes Prevention Program
Yes Health provides concierge health coaching and services for weight loss and diabetes prevention, all through its app. After taking a short quiz, members will receive a personalized plan — created by the company’s dietitians, nutritionists, fitness experts and psychologists — to improve their health. The app also offers an AI-powered service where members can take pictures of their meals to receive guidance on how to make them healthier.
-
RPM Must Be in the Standard of Care for Diabetes, Kaiser Physician Says
To help address the diabetes epidemic, providers should incorporate remote patient monitoring into the standard of care, according to Kaiser Permanente physician Dr. Sos Mboijana. When treating chronic conditions like diabetes, having access to a continuous flow of patient data is critical, he said.
-
How Ochsner Health’s RPM pilot improved outcomes for patients with diabetes, hypertension
Ochsner Health recently released the results of its digital health pilot program for Medicaid patients with hypertension and type 2 diabetes. The program, which combines remote patient monitoring with personalized care teams, did an efficient job at bringing down patients’ blood pressure and hemoglobin A1c levels.
-
The tale of two organs: Addressing menopause stigma
Should we start treating menopause as a disease condition? In our view, it’s a chronic disease condition that can go beyond two decades for some women, resulting in silent suffering.
-
Why improving maternal care could be impossible without VBC
This dearth of maternity care providers is exacerbating the country’s less-than-stellar reputation for birth outcomes. In order to ensure better health for mothers and their newborns, OB-GYNs must identify risk factors that negatively impact pregnancy early on and work to maintain the whole picture of their pregnant patients’ health. However, OB-GYNs aren’t incentivized to do this under a fee-for-service payment model.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
American Diabetes Association launches 3-year alliance to reduce amputations
The American Diabetes Association recently launched the Amputation Prevention Alliance — a three-year effort to decrease the number of diabetes-related amputations in the country — along with five partner organizations. The organizations will work together to advocate for policy changes, increase clinician education about caring for diabetic complications, and improve patients’ awareness of warning signs to watch out for.
-
Consumer / Employer, Pharmacy, SYN
RxBenefits, Tria Health form partnership for proactive diabetes care
RxBenefits, a pharmacy benefits optimizer, and Tria Health, a chronic condition and medication management company, have launched a new partnership to improve diabetes care and lower healthcare costs for the condition through a proactive approach.
-
Health Tech, Hospitals, MedCitizens, SYN
Mount Sinai, mPulse Mobile team up to reduce teenage diabetes
The rising levels of both type 1 and type 2 diabetes in American youth is quickly becoming a major public health concern. To help address this problem, Mount Sinai partnered with mPulse Mobile, a company that offers a AI-based mobile patient messaging platform. Together with a group of teenage community members, they created a text message-based youth diabetes prevention program focused on integrating healthy behaviors into teens’ lives.
-
Eli Lilly’s diabetes portfolio grows with FDA nod for projected blockbuster drug
The FDA approved Eli Lilly drug Mounjaro as a treatment for type 2 diabetes. The decision gives the pharmaceutical giant a new competitor to a blockbuster drug from rival Novo Nordisk, as well as a successor to its blockbuster diabetes drug Trulicity.
-
Devices & Diagnostics, BioPharma
Becton Dickinson spins off diabetes biz, enabling Embecta to embark on its own
The second quarter of 2022 kicked off with a new life sciences company joining the public markets, but not via an IPO or merger. Becton Dickinson on Friday completed the spinoff of its diabetes care business, Embecta, which now trades on the Nasdaq.
-
Devices & Diagnostics, Artificial Intelligence, BioPharma
Diabetes data put Better Therapeutics’ digital offering on track for FDA filing
Better Therapeutics reported that its digital therapeutic for type 2 diabetes met the main goal of a pivotal study. An FDA submission is expected in the middle of this year, followed by additional clinical trials testing digital therapeutics developed for other cardiometabolic disorders.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
